First Event of Infection by HIV-1 of Uterine Vaginal Tissue

Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001046 ·Status: WITHDRAWN ·Phase: PHASE1

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women

NCT02568215 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4

Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception

NCT01240811 ·Status: COMPLETED ·Phase: NA

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

NCT02411539 ·Status: COMPLETED ·Phase: PHASE1

BASTA Study on STI in HIV Infected Patients

NCT00310245 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

NCT00006444 ·Status: COMPLETED

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

NCT06144229 ·Status: ENROLLING_BY_INVITATION

Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials

NCT00789789 ·Status: TERMINATED

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

NCT01946139 ·Status: COMPLETED ·Phase: NA

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

NCT00710593 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption

NCT02463227 ·Status: COMPLETED ·Phase: PHASE1

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

NCT00695422 ·Status: COMPLETED

IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection

NCT01942655 ·Status: COMPLETED ·Phase: NA

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

NCT00205231 ·Status: COMPLETED ·Phase: NA

Combination Vaccination Before HIV Treatment Interruption

NCT00212888 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

Immune and Viral Outcomes of HIV-1 Therapy Interruption

NCT00051818 ·Status: COMPLETED ·Phase: PHASE1

Dendritic Cell Vaccine in HIV-1 Infection

NCT00402142 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS

NCT00002433 ·Status: COMPLETED ·Phase: NA

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

NCT04120415 ·Status: COMPLETED ·Phase: PHASE2

HIV Vaccine Study in HIV Positive Patients

NCT01071031 ·Status: COMPLETED ·Phase: PHASE1

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

NCT06812494 ·Status: RECRUITING ·Phase: PHASE2

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

NCT02591420 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults

NCT05627258 ·Status: COMPLETED ·Phase: PHASE1